Introduction: Neonatal Abstinence Syndrome (NAS) is a condition in newborns characterized by withdrawal symptoms due to in-utero exposure to certain substances, primarily opioids. This syndrome is increasingly common due to the rise in opioid use and addiction among pregnant women. Managing Neonatal Abstinence Syndrome (NAS) involves a combination of pharmacological and non-pharmacological strategies to alleviate withdrawal symptoms and support the infant’s overall health and development. Causes of Neonatal Abstinence Syndrome Neonatal Abstinence Syndrome (NAS) primarily results from prenatal exposure to opioids, but it can also be caused by other substances. Understanding the causes is crucial for prevention and management.…
-
-
Introduction: Neonatal sepsis is a severe medical condition occurring in newborns, characterized by systemic infection and inflammation. It remains a leading cause of neonatal morbidity and mortality worldwide. Moreover, Effective prevention and then timely treatment are important to improve outcomes for affected neonates. Preventing Neonatal Sepsis Prevention strategies for neonatal sepsis focus on reducing risk factors and then implementing proactive measures both during pregnancy and after delivery. Maternal Screening and Prophylaxis Group B Streptococcus (GBS) Screening: Pregnant women are routinely screened for GBS during the third trimester (35-37 weeks). Moreover, Intrapartum antibiotic prophylaxis (IAP) is administered to GBS-positive…